Diagnosis and anti-infective therapy of periodontitis

Expert Review of Anti-Infective Therapy

Volumn 5, Issue 4, 2007, Pages 703-715

  Horz, Hans Peter ^a   Conrads, Georg ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Chlorhexidine; Clindamycin; Culture; Enzymatic BANA test; Local delivery devices; Metronidazole; Nucleic acid based analysis; Penicillins; Periodontal pathogen; Periodontitis; Tetracyclines

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CAMURUS; CATECHIN; CEPHALOSPORIN; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; DOXYCYCLINE; DOXYCYCLINE HYCLATE; ETHYLENE VINYL ACETATE COPOLYMER; GELATINASE B; LEVOFLOXACIN; METRONIDAZOLE; MICROSPHERE; MINOCYCLINE; MOXIFLOXACIN; NEUTROPHIL COLLAGENASE; PENICILLIN G; PLACEBO; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ACTINOBACILLUS; ACTINOMYCETACEAE; ANOREXIA; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL THERAPY; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CAMPYLOBACTER RECTUS; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG ALCOHOL INTERACTION; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EIKENELLA CORRODENS; ENZYME ACTIVITY; ENZYME ASSAY; EPIGASTRIC DISCOMFORT; ESOPHAGITIS; FUSOBACTERIUM NUCLEATUM; GASTROINTESTINAL DISEASE; GENETIC SUSCEPTIBILITY; GINGIVITIS; HEADACHE; HUMAN; IMMUNOASSAY; LOW DRUG DOSE; MICROSCOPY; MONOTHERAPY; MOUTH HYGIENE; NAUSEA; NUCLEIC ACID ANALYSIS; PATHOGENESIS; PERIODONTITIS; PHOTOSENSITIVITY; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROTEIN SYNTHESIS INHIBITION; PSEUDOMEMBRANOUS COLITIS; RASH; REVIEW; RISK FACTOR; SMOKING; SPIROCHETE; STOMACH IRRITATION; STRESS; SUGAR INTAKE; SYSTEMATIC REVIEW; TANNERELLA FORSYTHENSIS; URETHRAL PAIN; VAGINAL BURNING SENSATION; VOMITING;

AMOXICILLIN; ANIMALS; ANTI-INFECTIVE AGENTS; CHLORHEXIDINE; CLINDAMYCIN; HUMANS; METRONIDAZOLE; MICROSCOPY; PENICILLINS; PERIODONTITIS; POLYMERASE CHAIN REACTION; SEROLOGIC TESTS; TETRACYCLINES;

EID: 34547854341     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.4.703     Document Type: Review

References (142)

1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Northwest Dent. 79(6), 31-35 (2000).
2. Petsen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull. World Health Organ. 83(9), 661-669 (2005).
3. Petersen PE, Ogawa H. Strengthening the prevention of periodontal disease: the WHO approach. J. Periodontol. 76(12), 87-2193 (2005).
4. Wiliershausen B, Krahwinkel T, Valentinis L, Todt M. Correlation between inflammatory periodontal diseases and cardiovascular diseases. Eur. J. Med. Res. 8(11), 499-504 (2003).
5. Persson GR. What has ageing to do with periodontal health and disease? Int. Dent. J. 56(4 Suppl. 4), 240-249 (2006).
6. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 366(9499), 1809-1820 (2005).
7. Renvert S, Pettersson T, Ohlsson O, Persson GR. Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. J. Periodontol. 77(7), 1110-1119 (2006).
8. Dumitrescu AL. Occurrenceo of self-reported systemic medical conditions in patients with periodontal disease. Rom. J. Intern. Med. 44(1), 35-48 (2006).
9. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessen J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am. Heart J. 151(5), 977-984 (2006).
10. Dortbudak O, Eberhardt R, Ulm M, Persson GR. Periodontitis, a marker of risk in pregnancy for preterm birth. J. Clin. Periodontol. 32(1), 45-52 (2005).
11. Page RC, Martin JA, Loeb CF. The Oral Health Information Suite (OHIS): its use in the management of periodontal disease. J. Dent. Educ. 69(5), 509-520 (2005).
12. Conrads G. Testing for marker bacteria in progressive periodontitis: the European experience. Infect. Dis. Clin. Pract. 10, 481-487 (2001).
13. Albert DA, Sadowsky D, Papapanou P, Conicella ML, Ward A. An examination of periodontal treatment and per member per month (PMPM) medical costs in an insured population. BMC Health Serv. Res. 6, 103 (2006).
14. Petersen PE. Priorities for research for oral health in the 21st Century - the approach of the WHO Global Oral Health Programme. Community Dent. Health 22(2), 71-74 (2005).
15. Ledder RG, Gilbert P, Huws SA et al. Molecular analysis of the subgingival microbiota in health and disease. Appl. Environ. Microbiol. 73(2), 516-523 (2007).
16. Kumar PS, Leys EJ, Bryk JM, Martinez FJ, Moeschberger ML, Griffen AL. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J. Clin. Microbiol. 44(10), 3665-3673 (2006).
17. Moter A, Riep B, Haban V. et al. Molecular epidemiology of oral treponemes in patients with periodontitis and in periodontitis-resistant subjects. J. Clin. Microbiol. 44(9), 3078-3085 (2006).
18. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25(2), 134-144 (1998).
19. Lepp PW, Brinig MM, Ouverney CC, Palm K, Armitage GC, Relman DA. Methanogenic Archaea and human periodontal disease. Proc. Natl Acad. Sci. USA 101(16), 6176-6181 (2004).
20. Vianna ME, Conrads G, Gomes BP, Horz HP. Identification and quantification of archaea involved in primary endodontic infections 1. J. Clin. Microbiol. 44(4), 1274-1282 (2006).
21. Robichaux M, Howell M, Boopathy R. Methanogenic activity in human periodontal pocket. Curr. Microbiol. 46(1), 53-58 (2003).
22. Yapar M, Saygun I, Ozdemir A, Kubar A, Sabin S. Prevalence of human herpesviruses in patients with aggressive periodontitis. J. Periodontol. 74(11), 1634-1640 (2003).
23. Ling LJ, Ho CC, Wu CY, Chen YT, Hung SL. Association between human herpesviruses and the severity of periodontitis. J. Periodontol. 75(11), 1479-1485 (2004).
24. Kubar A, Saygun I, Ozdemir A, Yapar M, Slots J. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. J. Periodontal Res. 40(2), 97-104 (2005).
25. Santangelo R, D'Ercole S, Graffec, R et al. Bacterial and viral DNA in periodontal disease: a study using multiplex PCR. New Microbiol. 27(2), 133-137 (2004).
26. Beikler T, Schnitzer S, Abdeen G, Ehmke B, Eisenacher M, Flemmig TF. Sampling strategy for intraoral detection of periodontal pathogens before and following periodontal therapy. J. Periodontol. 77(8), 1323-1332 (2006).
27. Greenstein G, Polson A. Microscopic monitoring of pathogens associated with periodontal diseases. A review. J. Periodontol. 56(12), 740-747 (1985).
28. Stender H. PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases. Expert Rev. Mol. Diagn. 3(5), 649-655 (2003).
29. Wardle HM. The challenge of growing oral spirochaetes. J. Med. Microbiol. 46(2), 104-116 (1997).
30. van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J. Clin. Periodontol. 32(8), 893-898 (2005).
31. Papaparaskevas J, Pantazatou A, Katsandri A, Legakis NJ, Avlamis A. Multicentre survey of the in vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clin. Microbiol. Infect. 11(10), 820-824 (2005).
32. Barbosa FC, Mayer MP, Saba-Chujfi E, Cai S. Subgingival occurrence and antimicrobial susceptibility of enteric rods and pseudomonads from Brazilian periodontitis patients. Oral Microbiol. Immunol. 16(5), 306-310 (2001).
33. Vianna ME, Horz HP, Gomes B, Conrads G. Microarrays complement culture methods for identification of bacteria in endodontic infections. Oral Microbiol. Immunol. 20, 253-258 (2005).
34. Lau L, Sanz M, Herrera D, Morillo JM, Martin C, Silva A. Quantitative real-time polymerase chain reaction versus culture: a comparison between two methods for the detection and quantification of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forphythensis in subgingival plaque samples. J. Clin. Periodontol. 31(12), 1061-1069 (2004).
35. Tsai CY, Wolff LF, Germaine G, Hodges J. A rapid DNA probe test compared to culture methods for identification of subgingival plaque bacteria. J. Clin. Periodontol. 30(1), 57-62 (2003).
36. Sanz M, Lau L, Herrera D, Morillo JM, Silva A. Methods of detection of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythensis in periodontal microbiology, with special emphasis on advanced molecular techniques: a review. J. Clin. Periodontol. 31(12), 1034-1047 (2004).
37. Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. Periodontal pathogens: a quantitative comparison of anaerobic culture and realtime PCR. FEMS Immunol. Med. Microbiol. 45(2), 191-199 (2005).
38. Verner C, Lemaitre P, Daniel A, Giumelli B, Lakhssassi N, Sixou M. Carpegen real-time polymerase chain reaction vs. anaerobic culture for periodontal pathogen identification. Oral Microbiol. Immunol. 21(6), 341-346 (2006).
39. Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. The additional value of real-time PCR in the quantitative detection of periodontal pathogens. J. Clin. Periodontol. 33(6), 427-433 (2006).
40. Loesche WJ, Lopatin DE, Giordano J, Alcoforado G, Hujoel P. Comparison of the benzoyl-DL-arginine-naphthylamide (BANA) test, DNA probes, and immunological reagents for ability to detect anaerobic periodontal infections due to Porphyromonas gingivalis, Treponema denticola, and Bacteroides forsythus. J. Clin. Microbiol. 30(2), 427-433 (1992).
41. Zuza EP, de Salis AM, de Toledo BE, Mendes AJ. Relationship between gingival clinical parameters and the reactivity of the BANA test in subgingival samples from children. J. Int. Acad. Periodontol. 8(3), 78-82 (2006).
42. Apsey DJ, Kaciroti N, Loesche WJ. The diagnosis of periodontal disease in private practice. J. Periodontol. 77(9), 1572-1581 (2006).
43. Faveri M, Gursky LC, Feres M, Shibli JA, Salvador SL, de Figueiredo LC. Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. J. Clin. Periodontol. 33(11), 819-828 (2006).
44. Herr AE, Hatch AV, Throckmorton DJ et al. Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc. Natl Acad. Sci. USA 104(13), 5268-5273 (2007).
45. Sorsa T, Tjaderhane L, Konttinen YT et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann. Med. 38(5), 306-321 (2006).
46. Verstappen J, Von den Hoff JW. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J. Dent. Res. 85(12), 1074-1084 (2006).
47. Gapski R, Barr JL, Sarment DP, Layher MG, Socransky SS, Giannobile WV. Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial. J. Periodontol. 75(3), 441-452 (2004).
48. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 10(6), 311-318 (2004).
49. Di Murro C, Paolantonio M, Pedrazzoli V, Lopatin DE, Cattabriga M. Occurrence of Porphyromonas gingivalis, Bacteroides forsythus, and Treponema denticola in periodontally healthy and diseased subjects as determined by an ELISA technique. J. Periodontol. 68(1), 18-23 (1997).
50. Booth V, Solakoglu O, Bavisha N, Curtis MA. Serum IgG1 and IgG2 antibody responses to Porphyromonas gingivalis in patients with periodontitis. Oral Microbiol. Immunol. 21(2), 93-99 (2006).
51. Ihara H, Miura T, Kato T et al. Detection of Campylobacter rectus in periodontitis sites by monoclonal antibodies. J. Periodontal Res. 38(1), 64-72 (2003).
52. Dahlen G, Leonhardt A. A new checkerboard panel for testing bacterial markers in periodontal disease. Oral Microbiol. Immunol. 21(1), 6-11 (2006).
53. Socransky SS, Haffajee AD, Smith C et al. Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol. Immunol. 19(6), 352-362 (2004).
54. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 9(1), 18-33 (1996).
55. Boutaga K, Savelkoul PH, Winkel EG, van Winkelhoff AJ. Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. J. Periodontol. 78(1), 79-86 (2007).
56. Caposio P, Torta AI, Romano F et al. Molecular approaches to the identification and treatment monitoring of periodontal pathogens. New Microbiol. 26(1), 121-124 (2003).
57. Kuboniwa M, Amano A, Kimura KR et al. Quantitative detection of periodontal pathogens using real-time polymerase chain reaction with TaqMan probes. Oral Microbiol. Immunol. 19(3), 168-176 (2004).
58. Nonnenmacher C, Dalpke A, Mutters R, Heeg K. Quantitative detection of periodontopathogens by real-time PCR. J. Microbiol. Methods 59(1), 117-125 (2004).
59. Suzuki N, Yoshida A, Nakano Y. Quantitative analysis of multi-species oral biofilms by TaqMan real-time PCR. Clin. Med. Res. 3(3), 176-185 (2005).
60. Takada K, Sakaguchi Y, Oka C, Hirasawa M. New rapid polymerase chain reaction-immunochromatographic assay for Porphyromonas gingivalis. J. Periodontol. 76(4), 508-512 (2005).
61. Bryant PA, Venter D, Robins-Browne R, Curtis N. Chips with everything: DNA microarrays in infectious diseases. Lancet Infect. Dis. 4(2), 100-111 (2004).
62. Campbell CJ, Ghazal P. Molecular signatures for diagnosis of infection: application of microarray technology. J. Appl. Microbiol. 96(1), 18-23 (2004).
63. Chari VL. Bacterial genomes and infectious diseases. Pediatr. Res. 54(1), 1-7 (2003).
64. Xiang CC, Chen Y. cDNA microarray technology and its applications. Biotechnol. Adv. 18(1), 35-46 (2000).
65. von Wintzingerode F, Gobet UB, Stackebrandt E. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol. Rev. 21(3), 213-229 (1997).
66. Agan S, Sonmez S, Serdar M. The effect of topical doxycycline usage on gingival crevicular fluid MMP-8 levels of chronic and aggressive periodontitis patients: a pilot study. Int. J. Dent. Hyg. 4(3), 114-121 (2006).
67. Marityla P, Stenman M, Kinane D et al. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J. Periodontal Res. 41(6), 503-512 (2006).
68. Conrads G, Flemmig TF, Seyfarth I, Lampert F, Lutticken R. Simultaneous detection of Bacteroides forsythus and Prevotella intermedia by 16S rRNA gene-directed multiplex PCR. J. Clin. Microbiol. 37(5), 1621-1624 (1999).
69. Bollen CM, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature. J. Periodontol. 67(11), 1143-1158 (1996).
70. Kornman KS. Controlled-release local delivery antimicrobials in periodontics: prospects for the future. J. Periodontol. 64(8 Suppl.), 782-791 (1993).
71. Drisko CL, Cobb CM, Killoy WJ et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J. Periodontol. 66(8), 692-699 (1995).
72. Garrett S, Adams DF, Bogle G et al. The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months. J. Periodontol. 71(1), 22-30 (2000).
73. Garrett S, Johnson L, Drisko CH et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, arid scaling and root planing in the treatment of periodontitis. J. Periodontol. 70(5), 490-503 (1999).
74. Newman MG, Kornman KS, Doherty FM. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J. Periodontol. 65(7), 685-691 (1994).
75. Purucker P, Mertes H, Goodson JM, Bernimoulin JP. Local versus systemic adjunctive antibiotic therapy in 28 patients with generalized aggressive periodontitis. J. Periodontol. 72(9), 1241-1245 (2001).
76. Radvar M, Pourtaghi N, Kinane DF. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets. J. Periodontol. 67(9), 860-865 (1996).
77. Page RC. The microbiological case for adjunctive therapy for periodontitis. J. Int. Acad. Periodontol. 6(4 Suppl.), 143-149 (2004).
78. Sakellari D, Vouros ID, Aristodemou E, Konstantinidis AB, Socransky S, Goodson M. Tetracycline fibers as an adjunct in the treatment of nifedipine-induced gingival enlargement. J. Periodontol. 76(6), 1034-1039 (2005).
79. Perinetti G, Paolantonio M, Cordella C, D'Ercole S, Serra E, Piccolomini R. Clinical and microbiological effects of subgingival administration of two active gels on persistent pockets of chronic periodontitis patients. J. Clin. Periodontol. 31(4), 273-281 (2004).
80. Zee KY, Lee DH, Corbet EF. Repeated oral hygiene instructions alone, or in combination with metronidazole dental gel with or without subgingival scaling in adult periodontitis patients: a one-year clinical study. J. Int. Acad. Periodontol. 8 (4), 125-135 (2006).
81. Walker CB, Karpinia K, Baehni P. Chemotherapeutics: antibiotics and other antimicrobials. Periodontol. 2000 36, 146-165 (2004).
82. Crout RJ, Lee HM, Schroeder K et al. The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J. Periodontol. 67(5), 506-514 (1996).
83. Cosyn J, Sabzevar MM. A systematic review on the effects of subgingival chlorhexidine gel administration in the treatment of chronic periodontitis. J. Periodontol. 76(11), 1805-1813 (2005).
84. Cosyn J, Wyn I. A systematic review on the effects of the chlorhexidine chip when used as an adjunct to scaling and root planing in the treatment of chronic periodontitis. J. Periodontol. 77(2), 257-264 (2006).
85. Grisi DC, Salvador SL, Figueiredo LC, Souza SL, Novaes AB, Grisi MF. Effect of a controlled-release chlorhexidine chip on clinical and microbiological parameters of periodontal syndrome. J. Clin. Periodontol. 29(10), 875-881 (2002).
86. Hoang T, Jorgensen MG, Keim RG, Pattison AM, Slots J. Povidone-iodine as a periodontal pocket disinfectant. J. Periodantal Res. 38(3), 311-317 (2003).
87. Zanatta GM, Bittencourt S, Nociti FH Jr, Sallum FA, Sallum AW, Casati MZ. Periodontal debridement with povidone-iodine in periodontal treatment: short-term clinical and biochemical observations. J. Periodontol. 77(3), 498-505 (2006).
88. Del Peloso Ribeiro E, Bittencourt S, Ambrosano GM et al. Povidone-iodine used as an adjunct to non-surgical treatment of furcation involvements. J. Periodontol. 77(2), 211-217 (2006).
89. Hirasawa M, Takada K, Makimura M, Otake S. Improvement of periodontal status by green tea catechin using a local delivery system: a clinical pilot study. J. Periodontal. Res. 37(6), 433-438 (2002).
90. Sastravaha G, Yotnuengnit P, Booncong P, Sangtherapitikul P. Adjunctive periodontal treatment with Centella asiatica and Punica granatum extracts. A preliminary study. J. Int. Acad. Periodontol. 5(4), 106-115 (2003).
91. Gordon JM, Walker CB, Goodson JM, Socransky SS. Sensitive assay for measuring tetracycline levels in gingival crevice fluid. Antimicrob. Agents Chemother. 17(2), 193-198 (1980).
92. Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS. Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingivai organisms. Part I. Concentrations in crevicular fluid after repeated doses. J. Periodontol. 52(10), 609-612 (1981).
93. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol. 2000 28, 106-176 (2002).
94. Slots J, Rosling BG. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J. Clin. Periodontol. 10(5), 465-486 (1983).
95. Novak MJ, Polson AM, Adair SM. Tetracycline therapy in patients with early juvenile periodontitis. J. Periodontol. 59(6), 366-372 (1988).
96. Muller HP, Lange DE, Muller RF. Failure of adjunctive minocycline-HCl to eliminate oral Actinobacillus actinomycetemcomitans. J. Clin. Periodontol. 20(7), 498-504 (1993).
97. Saxen L, Asikainen S, Kanervo, A, Kari K, Jousimies-Somer H. The long-term efficacy of systemic doxycycline medication in the treatment of localized juvenile periodontitis. Arch. Oral Biol. 35(Suppl.), 227S-229S (1990).
98. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann. Periodontol. 8(1), 115-181 (2003).
99. Buchmann R, Muller RF, Van Dyke TE, Lange DE. Change of antibiotic susceptibility following periodontal therapy. A pilot study in aggressive periodontal disease. J. Clin. Periodontol. 30(3), 222-229 (2003).
100. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 12(2), 12-26 (1998).
101. Golub LM, Lee HM, Greenwald RA et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm. Res. 46(8), 310-319 (1997).
102. Golub LM, Sorsa T, Lee HM et al. Doxycycline inhibits neutrophil (PMN)- type matrix metalloproteinases in human adult periodontitis gingiva. J. Clin. Periodontol. 22(2), 100-109 (1995).
103. Ashley RA. Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team. Ann. NY Acad. Sci. 878, 335-346 (1999).
104. Caton JG, Ciancio SG, Blieden TM et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects. J. Clin. Periodontol. 28(8), 782-789 (2001).
105. Caton JG, Ciancio SG, Blieden TM et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J. Periodontol. 71(4), 521-532 (2000).
106. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J. Periodontol. 75(1) 106-115 (2004).
107. Emingil G, Atilla G, Sorsa T, Savolainen P, Baylas H. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 γ2 chain levels in chronic periodontitis. J. Periodontol. 75(10), 1387-1396 (2004).
108. Lee HM, Ciancio SG, Tuter G, Ryan ME, Komaroff E, Golub LM. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J. Periodontol. 75(3), 453-463 (2004).
109. Skidmore R, Kovach R, Walker C et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch. Dermatol. 139(4), 459-464 (2003).
110. Thomas J, Walker C, Bradshaw M. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J. Periodontol. 71(9), 1472-1483 (2000).
111. Thomas JG, Metheny RJ, Karakiozis JM, Wetzel JM, Crour RJ. Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics. Adv. Dent. Res. 12(2), 32-39 (1998).
112. Walker CB, Gordon JM, Cornwall HA, Murphy JC, Socransky SS. Gingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentrations for periodontal bacteria. Antimicrob. Agents Chemother. 19(5), 867-871 (1981).
113. Gordon J, Walker C, Hovliaras C, Socransky S. Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-month results. J. Periodontol. 61(11), 686-691 (1990).
114. Gordon J, Walker C, Lamster I et al. Efficacy of clindamycin hydrochloride in refractory periodontitis. 12-month results. J. Periodontol. 56(11 Suppl.), 75-80 (1985).
115. Magnusson I, Low SB, McArthur WP et al. Treatment of subjects with refractory periodontal disease. J. Clin. Periodontol. 21(9), 628-637 (1994).
116. Brook I, Lewis MA, Sandor GK, Jeffcoat M, Samaranayake LP, Vera Rojas J. Clindamycin in dentistry: more than just effective prophylaxis for endocarditis? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100(5), 550-558 (2005).
117. Lakhssassi N, Elhajoui N, Lodter JP, Pineill JL, Sixou M. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study. Oral Microbiol. Immunol. 20(4), 244-252 (2005).
118. Eick S, Pfister W, Fiedler D, Straube E. Clindamycin promotes phagocytosis and intracellular killing of periodontopathogenic bacteria by crevicular granulocytes: an in vitro study. J. Antimicrob. Chemother. 46(4), 583-588 (2000).
119. Walker CB, Tyler KZ, Low SB, King CJ. Penicillin-degrading enzymes in sites associated with adult periodontitis. Oral Microbiol. Immunol. 2(3), 129-131 (1987).
120. Winkel EG, van Winkelhoff AJ, Barendregt DS, van der Weijden GA, Timmerman MF, van der Velden U. Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study. J. Clin. Periodontol. 26(7), 461-468 (1999).
121. Bascones-Martinez A, Figuero-Ruiz E. Periodontal diseases as bacterial infection. Med. Oral Patol. Oral Cir. Bucal. 9(Suppl.), 100-107 (2004).
122. Liebana J, Castillo AM, Alvarez M. Periodontal diseases: microbiological considerations. Med. Oral Patol. Oral Cir. Bucal. 9(Suppl.) 82-91 (2004).
123. Snydman DR, Jacobus NV, McDermott LA et al. National survey on the susceptibility of B. fragilis group: report and analysis of trends for 1997-2004: a US survey. Antimicrob. Agents Chemother. 51(5), 1649-1655 (2007).
124. Lofmark S, Fang H, Hedberg M, Edlund C. Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates. Antimicrob. Agents Chemother. 49(3), 1253-1256 (2005).
125. Poulet PP, Duffaut D, Lodter JP. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease. J. Clin. Periodontol. 26(4), 261-263 (1999).
126. Van Oosten MA, Notten FJ, Mikx FH. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. J. Dent. Res. 65(12), 1420-1423 (1986).
127. Muller HP, Holderrieth S, Burkhardt U, Hoffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J. Clin. Periodontol. 29(8), 736-742 (2002).
128. Soder B, Nedlich U, Jin LJ. Longitudinal effect of non-surgical treatment and systemic metronidazole for 1 week in smokers and non-smokers with refractory periodontitis: a 5-year study. J. Periodontol. 70(7), 761-771 (1999).
129. Carvalho LH, D'Avila GB, Leao A, Haffajee AD, Socransky SS, Feres M. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. Clinical results. J. Clin. Periodontol. 31(12), 1070-1076 (2004).
130. Sobottka I, Cachovan G, Sturenburg E et al. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob. Agents Chemother. 46(12), 4019-4021 (2002).
131. Eick S, Schmitt A, Sachse S, Schmidt KH, Pfister W. In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains. J. Antimicrob. Chemother. 54(2), 553-556 (2004).
132. van Winkelhoff AJ, Rodenburg JP, Goene RJ, Abbas F, Winkel EG, de Graaff J. Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J. Clin. Periodontol. 16(2), 128-131 (1989).
133. Flemmig TF, Milian E, Karch H, Klaiber B. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porohyromonas gingivalis. J. Clin. Periodontol. 25(5), 380-387 (1998).
134. Pavicic MJ, van Winkelhoff AJ, Douque NH, Steures RW, de Graaff J. Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans- associated periodontitis. A 2-year evaluation. J. Clin. Periodontol. 21(2), 107-112 (1994).
135. Tinoco EM, Beldi MI, Campedelli F et al. Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial. J. Periodontol. 69(12), 1355-1363 (1998).
136. Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J. Clin. Periodontol. 28(4), 296-305 (2001).
137. Rooney J, Wade WG, Sprague SV, Newcombe RG, Addy M. Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxycillin alone and combined. A placebo controlled study. J. Clin. Periodontol. 29(4), 342-350 (2002).
138. Guerrero A, Griffiths GS, Nibali L et al. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J. Clin. Periodontol. 32(10), 1096-1107 (2005).
139. Slots J, Feik D, Rams TE. In vitro antimicrobial sensitivity of enteric rods and pseudomonads from advanced adult periodontitis. Oral Microbiol. Immunol. 5(5), 298-301 (1990).
140. Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 10, 79-88 (1996).
141. Lacroix JM, Walker C. Characterization of a β-lactamase found in Eikenella corrodens. Antimicrob. Agents Chemother. 35(5), 886-891 (1991).
142. Slots J, Feik D, Rams TE. Prevalence and antimicrobial susceptibility of Enterobactcriaceae, Pseudomonadaceae and Acinetobacter in human periodontitis. Oral Microbiol. Immunol. 5(3), 149-154 (1990).